|16.72||-0.18 / -1.07%|
Data as of 3:59pm ET
|16.72||-0.002 / -0.01%|
The 8 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 21.50, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +28.59% increase from the last price of 16.72.
The current consensus among 9 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.